Daily mesalamine as good as twice-a-day dosing for UC

11/8/2009 | Medscape (free registration)

Researchers said they were surprised to find that once-daily doses of delayed-release mesalamine were as effective at keeping ulcerative colitis in remission as a twice-a-day regimen. The study, presented at the ACG Annual Scientific Meeting, also showed daily dosing improved patient compliance.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Stryker
Mahwah, NJ
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA